Group One Trading
HCAT icon

Group One Trading’s Health Catalyst HCAT Stock Holding History

Group One Trading’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$378 Buy
+190
New +$274 ﹤0.01% 7334
2026
Q1 		– Sell
-86
Closed -$162 – 8064
2025
Q4 		$206 Hold
86
– – ﹤0.01% 7885
2025
Q3 		$245 Sell
86
-2,000
-96% -$6.85K ﹤0.01% 8205
2025
Q2 		$7.86K Hold
2,086
– – ﹤0.01% 6865
2025
Q1 		$9.45K Sell
2,086
-2,274
-52% -$12K ﹤0.01% 6295
2024
Q4 		$30.8K Buy
4,360
+2,260
+108% +$18K ﹤0.01% 5414
2024
Q3 		$17.1K Buy
2,100
+2,000
+2,000% +$14.5K ﹤0.01% 5317
2024
Q2 		$639 Buy
+100
New +$642 ﹤0.01% 6426
2022
Q4 		– Sell
-11,933
Closed -$115K – 7569
2022
Q3 		$116K Buy
+11,933
New +$158K ﹤0.01% 4642
2020
Q2 		– Sell
-538
Closed -$14.9K – 5932
2020
Q1 		$14K Buy
+538
New +$16.4K ﹤0.01% 4420

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's HCAT Position: Q2 2026 in Review

Group One Trading opened a new position in Health Catalyst (HCAT) in Q2 2026: 190 shares worth $378. The stake represents ﹤0.01% of the portfolio and ranks #7334 among its holdings. This is a return to the name: Group One Trading previously reported a position in HCAT as recently as Q4 2025.

Group One Trading first reported a position in HCAT in Q1 2020 and has held it in 10 quarters since. The position peaked at $116K in Q3 2022. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Group One Trading held 190 shares of Health Catalyst worth $378 as of Q2 2026.
  • Health Catalyst was a new Group One Trading position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7334 holding.
  • Group One Trading first reported a position in Health Catalyst in Q1 2020 and has held it in 10 quarters since.
  • Group One Trading's Health Catalyst position peaked at $116K in Q3 2022.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.